Greub G - Search Results

1

Clinical implications of Mycobacterium kansasii species heterogeneity: Swiss National Survey.

Taillard C, Greub G, Weber R, Pfyffer GE, Bodmer T, Zimmerli S, Frei R, Bassetti S, Rohner P, Piffaretti JC, Bernasconi E, Bille J, Telenti A, Prod'hom G. Taillard C, et al. Among authors: greub g. J Clin Microbiol. 2003 Mar;41(3):1240-4. doi: 10.1128/JCM.41.3.1240-1244.2003. J Clin Microbiol. 2003. PMID: 12624057 Free PMC article.

2

Enterococcus cecorum septicemia in a malnourished adult patient.

Greub G, Devriese LA, Pot B, Dominguez J, Bille J. Greub G, et al. Eur J Clin Microbiol Infect Dis. 1997 Aug;16(8):594-8. doi: 10.1007/BF02447923. Eur J Clin Microbiol Infect Dis. 1997. PMID: 9323472

3

Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study.

Greub G, Ledergerber B, Battegay M, Grob P, Perrin L, Furrer H, Burgisser P, Erb P, Boggian K, Piffaretti JC, Hirschel B, Janin P, Francioli P, Flepp M, Telenti A. Greub G, et al. Lancet. 2000 Nov 25;356(9244):1800-5. doi: 10.1016/s0140-6736(00)03232-3. Lancet. 2000. PMID: 11117912 Clinical Trial.

4

Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients.

Marzolini C, Telenti A, Decosterd LA, Greub G, Biollaz J, Buclin T. Marzolini C, et al. Among authors: greub g. AIDS. 2001 Jan 5;15(1):71-5. doi: 10.1097/00002030-200101050-00011. AIDS. 2001. PMID: 11192870

5

Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study.

Fellay J, Boubaker K, Ledergerber B, Bernasconi E, Furrer H, Battegay M, Hirschel B, Vernazza P, Francioli P, Greub G, Flepp M, Telenti A; Swiss HIV Cohort Study. Fellay J, et al. Among authors: greub g. Lancet. 2001 Oct 20;358(9290):1322-7. doi: 10.1016/s0140-6736(01)06413-3. Lancet. 2001. PMID: 11684213

6

HIV lipoatrophy and mosquito bites.

Greub G, Fellay J, Telenti A. Greub G, et al. Clin Infect Dis. 2002 Jan 15;34(2):288-9. doi: 10.1086/323014. Clin Infect Dis. 2002. PMID: 11740720 No abstract available.

7

Spare post-exposure prophylaxis with round-the-clock HIV testing of the source patient.

Greub G, Maziéro A, Bürgisser P, Telenti A, Francioli P. Greub G, et al. AIDS. 2001 Dec 7;15(18):2451-2. doi: 10.1097/00002030-200112070-00014. AIDS. 2001. PMID: 11774831

8

Aspergillus species isolated from clinical specimens: suggested clinical and microbiological criteria to determine significance.

Greub G, Bille J. Greub G, et al. Clin Microbiol Infect. 1998 Feb;4(12):710-716. doi: 10.1111/j.1469-0691.1998.tb00656.x. Clin Microbiol Infect. 1998. PMID: 11864279 Free article.

9

The detection of mycobacteria in blood cultures using the Bactec system: 6 weeks versus 12 weeks of incubation? routine terminal Ziel-Neelsen?

Greub G, Jaton K, Beer V, Prod'hom G, Bille J. Greub G, et al. Clin Microbiol Infect. 1998 Jul;4(7):401-404. doi: 10.1111/j.1469-0691.1998.tb00085.x. Clin Microbiol Infect. 1998. PMID: 11864356 Free article. No abstract available.

10

Spare non-occupational HIV post-exposure prophylaxis by active contacting and testing of the source person.

Greub G, Gallant S, Zurn P, Vannotti M, Bürgisser P, Francioli P, Zanetti G, Telenti A. Greub G, et al. AIDS. 2002 May 24;16(8):1171-6. doi: 10.1097/00002030-200205240-00011. AIDS. 2002. PMID: 12004276

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

538 results

Search Page

Filters